Addictive health disorders have a broad impact on the lives of those who suffer from these conditions, as well as their families and communities. PARCKA staff engage in research in a number of different areas that span the continuum of health care, treatment, and services. Investigators specialize in behavioral health services research, which includes epidemiological, observational, experimental, quasi-experimental, implementation, and evaluative research. Recognizing the vast impact of addiction, PARCKA investigators focus on populations that have disproportionate risk for substance use, such as individuals who are homeless, veterans, suffer from chronic pain or psychiatric illness, and/or identify as LGBTQIA+.
The Greater Intermountain Node
The Greater Intermountain Node (GIN) is housed within PARCKA and leverages robust institutional commitment and infrastructure, institutional centers focused on addiction-related research, and training programs with strong regional and national connections to clinicians, educators, other institutions and organizations, and community stakeholders. The GIN brings particular expertise in opioid addiction research to the Utah, regional, and national communities. The following studies are currently participating within the GIN:
- CTN-0080: Medication Treatment for Opioid-dependent Expecting Mothers (MOMs): A Pragmatic Randomized Trial Comparing Two Buprenorphine Formulations
- CTN-0099: Emergency Department-INitiated BupreNOrphine VAlidaTIOn Network Trial (ED-INNOVATION)
- CTN-0100: Optimizing Retention, Duration, and Discontinuation Strategies for Opioid Use Disorder (RDD)
- CTN-0101: The Healthy Living Study
- CTN-0116: Implementing a Pharmacist-Integrated Collaborative Model of Medication Treatment for Opioid Use Disorder (PharmICO) Study
- CTN-0121: Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders (SUD) among Hospitalized Patients.
- CTN-0138: Adaptation and Implementation of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool (PharmTool)